Novo Nordisk cuts forecasts amid U.S. drug rivalry, with compounded versions and Eli Lilly competition limiting its weight-loss drug Wegovy's market penetration.
Congressman Krishnamoorthi enters competitive Illinois Senate primary, highlighting his immigrant background and advocacy for working families, reproductive freedom, and healthcare access.
Novo Nordisk cuts forecasts amid U.S. drug rivalry, with compounded versions and Eli Lilly competition limiting its weight-loss drug Wegovy's market penetration.
Congressman Krishnamoorthi enters competitive Illinois Senate primary, highlighting his immigrant background and advocacy for working families, reproductive freedom, and healthcare access.
